Company: WHWK
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001628280-25-020311
Chunk: 52

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 52
---
 and

• any of our directors (including director nominees), executive officers, or beneficial holders of more than 5% of any class of our voting securities, or any immediate family member of, or person sharing the household with, any of these individuals or entities, had or will have a direct or indirect material interest.

#### PIPE Financing and Subscription Agreement
On December 19, 2024, we entered into a subscription agreement (the "Subscription Agreement") with each of the purchasers named therein (the “PIPE Investors”), pursuant to which we agreed to sell to the PIPE Investors (i) 21,592,000 shares of our common stock, at a purchase price of $2.40 per share, and (ii) 20,076,500 pre-funded warrants to acquire common stock (the "Pre-Funded Warrants"), at a purchase price of $2.3999 per Pre-Funded Warrant, for an aggregate purchase price of $100 million (collectively, the “PIPE Financing”). The Pre-Funded Warrants have an exercise price of $0.0001 per share of common stock, are immediately exercisable, and remain exercisable until exercised in full. The holders of Pre-Funded Warrants may not exercise a Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% or 9.99%, at the election of the holder, of the number of shares of common stock outstanding immediately after giving effect to such exercise. The holders of Pre-Funded Warrants may increase or decrease such percentages not in excess of 19.99% by providing at least 61 days’ prior notice to us.

The PIPE Financing closed on March 4, 2025.

#### Registration Rights Agreement
At the closing of the PIPE Financing, in connection with the Subscription Agreement, we entered into a Registration Rights Agreement with the PIPE Investors. Pursuant to the Registration Rights Agreement, we prepared and filed a resale registration statement with the SEC on March 31, 2025, which was declared effective by the SEC on April 8, 2025.

We also agreed, among other things, to indemnify each participating holder, their officers, directors, members, employees, and agents, successors and assigns, and each other person, if any, who controls such participating holder within the meaning of the Securities Act of 1933, as amended (the “Securities Act”), under the registration statement from certain losses, claims, damages, liabilities and expenses